225 research outputs found
Superconducting gap anisotropy of LuNi2B2C thin films from microwave surface impedance measurements
Surface impedance measurements of LuNi2B2C superconducting thin films as a
function of temperature have been performed down to 1.5 K and at 20 GHz using a
dielectric resonator technique. The magnetic penetration depth closely
reproduces the standard B.C.S. result, but with a reduced value of the energy
gap at low temperature. These data provide evidence for an anisotropic s-wave
character of the order parameter symmetry in LuNi2B2C. From the evaluation of
the real part of complex conductivity, we have observed constructive (type II)
coherence effects in the electromagnetic absorption below Tc.Comment: 15 pages, 4 figure
Effect of magnetic order on the superfluid response of single-crystal ErNiBC: A penetration depth study
We report measurements of the in-plane magnetic penetration depth (T) in single crystals of ErNiBC down to 0.1 K using
a tunnel-diode based, self-inductive technique at 21 MHz. We observe four
features: (1) a slight dip in (T) at the Nel
temperature = 6.0 K, (2) a peak at = 2.3 K, where a weak
ferromagnetic component sets in, (3) another maximum at 0.45 K, and (4) a final
broad drop down to 0.1 K. Converting to superfluid density , we see
that the antiferromagnetic order at 6 K only slightly depresses
superconductivity. We seek to explain some of the above features in the context
of antiferromagnetic superconductors, where competition between the
antiferromagnetic molecular field and spin fluctuation scattering determines
increased or decreased pairbreaking. Superfluid density data show only a slight
decrease in pair density in the vicinity of the 2.3 K feature, thus supporting
other evidences against bulk ferromagnetism in this temperature range.Comment: 15 pages, 5 figure
Microwave Electrodynamics of Electron-Doped Cuprate Superconductors
We report microwave cavity perturbation measurements of the temperature
dependence of the penetration depth, lambda(T), and conductivity, sigma(T) of
Pr_{2-x}Ce_{x}CuO_{4-delta} (PCCO) crystals, as well as parallel-plate
resonator measurements of lambda(T) in PCCO thin films. Penetration depth
measurements are also presented for a Nd_{2-x}Ce_{x}CuO_{4-delta} (NCCO)
crystal. We find that delta-lambda(T) has a power-law behavior for T<T_c/3, and
conclude that the electron-doped cuprate superconductors have nodes in the
superconducting gap. Furthermore, using the surface impedance, we have derived
the real part of the conductivity, sigma_1(T), below T_c and found a behavior
similar to that observed in hole-doped cuprates.Comment: 4 pages, 4 figures, 1 table. Submitted to Physical Review Letters
revised version: new figures, sample characteristics added to table, general
clarification give
Anomalous Low Temperature Behavior of Superconducting Nd(1.85)Ce(0.15)CuO(4-y)
We have measured the temperature dependence of the in-plane London
penetration depth lambda(T) and the maximum Josephson current Ic(T) using
bicrystal grain boundary Josephson junctions of the electron-doped cuprate
superconductor Nd(1.85)Ce(0.15)CuO(4-y). Both quantities reveal an anomalous
temperature dependence below about 4 K. In contrast to the usual monotonous
decrease (increase) of lambda(T) (Ic(T)) with decreasing temperature, lambda(T)
and Ic(T) are found to increase and decrease, respectively, with decreasing
temperature below 4 K resulting in a non-monotonous overall temperature
dependence. This anomalous behavior was found to be absent in analogous
measurements performed on Pr(1.85)Ce(0.15)CuO(4-y). From this we conclude that
the anomalous behavior of Nd(1.85)Ce(0.15)CuO(4-y) is caused by the presence of
the Nd3+ paramagnetic moments. Correcting the measured lambda(T) dependence of
Nd(1.85)Ce(0.15)CuO(4-y) for the temperature dependent susceptibility due to
the Nd moments, an exponential dependence is obtained indicating isotropic
s-wave pairing. This result is fully consistent with the lambda(T) dependence
measured for Pr(1.85)Ce(0.15)CuO(4-y).Comment: 4 pages including 4 figures, to appear in Phys. Rev. Let
Systematics of two-component superconductivity in from microwave measurements of high quality single crystals
Systematic microwave surface impedance measurements of YBCO single crystals
grown in crucibles reveal new properties that are not directly seen
in similar measurements of other YBCO samples. Two key observations obtained
from complex conductivity are: a new normal conductivity peak at around 80K and
additional pairing below 65K. High pressure oxygenation of one of the crystals
still yields the same results ruling out any effect of macroscopic segregation
of O-deficient regions. A single complex order parameter cannot describe these
data, and the results suggest at least two superconducting components.
Comparisons with model calculations done for various decoupled two-component
scenarios (i.e. s+d, d+d) are presented. Systematics of three single crystals
show that the 80K quasiparticle peak is correlated with the normal state
inelastic scattering rate. Close to Tc, the data follow a mean-field behavior.
Overall, our results strongly suggest the presence of multiple pairing
temperature and energy scales in .Comment: 14 pages, 2-column, Revtex, 5 embedded postscript figures, uses
graphicx. Postscript version also available at
http://sagar.physics.neu.edu/preprints.htm
Anisotropic conductivity of Nd_{1.85}Ce_{0.15}CuO_{4-\delta} films at submillimeter wavelengths
The anisotropic conductivity of thin NdCeCuO
films was measured in the frequency range 8 cm 40 cm and
for temperatures 4 K K. A tilted sample geometry allowed to extract
both, in-plane and c-axis properties. The in-plane quasiparticle scattering
rate remains unchanged as the sample becomes superconducting. The temperature
dependence of the in-plane conductivity is reasonably well described using the
Born limit for a d-wave superconductor. Below T_{{\rm C}%} the c-axis
dielectric constant changes sign at the screened c-axis plasma
frequency. The temperature dependence of the c-axis conductivity closely
follows the linear in T behavior within the plane.Comment: 4 pages, 4 figure
An Ontological Approach to Inform HMI Designs for Minimizing Driver Distractions with ADAS
ADAS (Advanced Driver Assistance Systems) are in-vehicle systems designed to enhance driving
safety and efficiency as well as comfort for drivers in the driving process. Recent studies have
noticed that when Human Machine Interface (HMI) is not designed properly, an ADAS can cause
distraction which would affect its usage and even lead to safety issues. Current understanding of
these issues is limited to the context-dependent nature of such systems. This paper reports the
development of a holistic conceptualisation of how drivers interact with ADAS and how such
interaction could lead to potential distraction. This is done taking an ontological approach to
contextualise the potential distraction, driving tasks and user interactions centred on the use of
ADAS. Example scenarios are also given to demonstrate how the developed ontology can be used
to deduce rules for identifying distraction from ADAS and informing future designs
The restorative role of annexin A1 at the blood–brain barrier
Annexin A1 is a potent anti-inflammatory molecule that has been extensively studied in the peripheral immune
system, but has not as yet been exploited as a therapeutic target/agent. In the last decade, we have undertaken the
study of this molecule in the central nervous system (CNS), focusing particularly on the primary interface between the
peripheral body and CNS: the blood–brain barrier. In this review, we provide an overview of the role of this molecule
in the brain, with a particular emphasis on its functions in the endothelium of the blood–brain barrier, and the protective
actions the molecule may exert in neuroinflammatory, neurovascular and metabolic disease. We focus on the
possible new therapeutic avenues opened up by an increased understanding of the role of annexin A1 in the CNS
vasculature, and its potential for repairing blood–brain barrier damage in disease and aging
Photography-based taxonomy is inadequate, unnecessary, and potentially harmful for biological sciences
The question whether taxonomic descriptions naming new animal species without type specimen(s) deposited in collections should be accepted for publication by scientific journals and allowed by the Code has already been discussed in Zootaxa (Dubois & Nemésio 2007; Donegan 2008, 2009; Nemésio 2009a–b; Dubois 2009; Gentile & Snell 2009; Minelli 2009; Cianferoni & Bartolozzi 2016; Amorim et al. 2016). This question was again raised in a letter supported
by 35 signatories published in the journal Nature (Pape et al. 2016) on 15 September 2016. On 25 September 2016, the following rebuttal (strictly limited to 300 words as per the editorial rules of Nature) was submitted to Nature, which on
18 October 2016 refused to publish it. As we think this problem is a very important one for zoological taxonomy, this text is published here exactly as submitted to Nature, followed by the list of the 493 taxonomists and collection-based
researchers who signed it in the short time span from 20 September to 6 October 2016
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
The multimodal activities of farnesoid X receptor (FXR) agonists make this class an attractive option to treat nonalcoholic steatohepatitis. The safety and efficacy of tropifexor, an FXR agonist, in a randomized, multicenter, double-blind, three-part adaptive design, phase 2 study, in patients with nonalcoholic steatohepatitis were therefore assessed. In Parts A + B, 198 patients were randomized to receive tropifexor (10–90 μg) or placebo for 12 weeks. In Part C, 152 patients were randomized to receive tropifexor 140 μg, tropifexor 200 μg or placebo (1:1:1) for 48 weeks. The primary endpoints were safety and tolerability to end-of-study, and dose response on alanine aminotransferase (ALT), aspartate aminotransferase (AST) and hepatic fat fraction (HFF) at week 12. Pruritus was the most common adverse event in all groups, with a higher frequency in the 140- and 200-μg tropifexor groups. Decreases from baseline in ALT and HFF were greater with tropifexor versus placebo at week 12, with a relative decrease in least squares mean from baseline observed with all tropifexor doses for ALT (tropifexor 10–90-μg dose groups ranged from −10.7 to −16.5 U l−1 versus placebo (−7.8 U l−1) and tropifexor 140- and 200-μg groups were −18.0 U l−1 and −23.0 U l−1, respectively, versus placebo (−8.3 U l−1)) and % HFF (tropifexor 10–90-μg dose groups ranged from −7.48% to −15.04% versus placebo (−6.19%) and tropifexor 140- and 200-μg groups were −19.07% and −39.41%, respectively, versus placebo (−10.77%)). Decreases in ALT and HFF were sustained up to week 48; however, similar trends in AST with tropifexor at week 12 were not observed. As with other FXR agonists, dose-related pruritus was frequently observed. Clinicaltrials.gov registration: NCT02855164
- …
